St. Jude Medical, Inc. (NYSE:STJ)

CAPS Rating: 4 out of 5

Develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices for the management of chronic pain.

Results 1 - 20 of 60 : 1 2 3 Next »

Recs

1
Member Avatar Teacherman333 (47.75) Submitted: 5/19/2013 1:28:07 PM : Outperform Start Price: $43.03 STJ Score: +21.65

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 18.48%
Trailing PE 18.91
PB 3.54
Div yield 2.10%

Recs

0
Member Avatar chris293 (82.79) Submitted: 1/23/2013 4:55:46 PM : Outperform Start Price: $38.64 STJ Score: +26.53

Another medical with a charity tie in. And east coast to boot plus its' good name.

Recs

0
Member Avatar WITTness13 (22.83) Submitted: 11/25/2012 10:11:39 PM : Outperform Start Price: $30.98 STJ Score: +58.21

Buying Opp. Overreaction, at least $40 stock

Recs

0
Member Avatar chopchop0 (50.30) Submitted: 11/21/2012 1:56:52 PM : Outperform Start Price: $29.78 STJ Score: +65.12

Buying the panic

Recs

0
Member Avatar Manifest (81.61) Submitted: 5/24/2012 2:11:54 PM : Outperform Start Price: $37.17 STJ Score: +14.91

We have St. Jude Medical (STJ) with a projected annual return of approximately 15% (market is 8-9% right now) and an excellent (top quintile) quality rating.

Recs

0
Member Avatar Marlonito9 (< 20) Submitted: 5/13/2012 9:44:30 PM : Underperform Start Price: $37.32 STJ Score: -17.52

I think its best this way. I hope I can receive money by this.

Recs

0
Member Avatar BKITU (95.19) Submitted: 1/18/2012 3:18:18 PM : Outperform Start Price: $35.66 STJ Score: +20.98

Medical equipment -- primarily coronary -- is only going to be a growth industry for at least the next five years. Solid financials, good net income.

Recs

0
Member Avatar clbjblk (< 20) Submitted: 10/30/2011 3:01:45 AM : Outperform Start Price: $37.36 STJ Score: +8.75

I have an implant in my neck,after 4 yrs of surguries it did what they said,there goal was to releive pain and get me off medicines by 40 to 50% because there is no cure for what i have.I have it for 1 yr now and i am much better off than I was,so I bought 100 shares at 38.78 because it worked like they said,I hope the stock goes up,but I bought it because it helped,I had several opinions from sever neuro surgens and they all said go with stj above the rest they all said it was much better than other med devices.I was in houston med center and I still hurt and have to take strong meds but not like before.So my moral to this is sentimental but I wanted to thank them ,and indirectly this is how I did,just be careful and do not break your neck but they are no 1 in my book,so it is what it is,I just hope there stock goes up so they can help more people and they can spend more in R@D and help others,and I could use the change in my pocket even though I have someone get it out of my pocket for me.

Recs

0
Member Avatar lumbergh79 (< 20) Submitted: 10/17/2011 7:16:15 PM : Underperform Start Price: $35.20 STJ Score: -9.76

As stated by others, the ICD market is growing, but at a MUCH slower pace than anticipated a few years ago and average sales prices are dropping rapidly. More importantly, one of STJ's ICD leads, Riata, will likely end up being recalled by the FDA soon. ICD's make up a very large percentage of STJ's total revenue. Studies have begun to be published showing a structural failure rate around 15%. A recall could have a major impact (patient safety issues, law suits, loss of credibility with doctors, etc). Although STJ now sells a modified version of the Riata marketed under the name Durata, the modified lead appears to have the same basic design as the Riata. If a recall of the Riata occurs, Durata COULD be right behind it. That would leave St. Jude without an FDA approved ICD lead...and in big trouble.

Recs

0
Member Avatar TMFRisingStars (< 20) Submitted: 7/26/2011 2:38:05 PM : Outperform Start Price: $44.99 STJ Score: -11.74

Here's the buy rec:
http://www.fool.com/investing/general/2011/07/25/rising-star-buy-st-jude-medical.aspx

Recs

0
Member Avatar TMFJMo (70.50) Submitted: 7/25/2011 8:18:47 PM : Outperform Start Price: $45.35 STJ Score: -12.83

Rising Star Buy: http://www.fool.com/investing/general/2011/07/25/rising-star-buy-st-jude-medical.aspx

Recs

0
Member Avatar mbawharton (47.31) Submitted: 6/20/2011 12:37:23 PM : Outperform Start Price: $45.99 STJ Score: -21.62

Found this from my stock screener.

Recs

0
Member Avatar teknologic (< 20) Submitted: 4/1/2011 5:13:47 PM : Outperform Start Price: $38.92 STJ Score: +5.47

1x - 4/1

Recs

0
Member Avatar clark1943 (81.92) Submitted: 4/26/2010 12:56:28 AM : Outperform Start Price: $38.14 STJ Score: -1.51

From relative pe screen. My price target 52.02

Recs

2
Member Avatar thethirdchimp (< 20) Submitted: 4/12/2010 6:17:50 AM : Outperform Start Price: $38.08 STJ Score: -4.13

Demographics around the world indicate a growing population over the age of 65 in developed countries and a richer, broader middle class in emerging markets. The demand for healthcare and heart-related equipment/supplies will rise substantially year over year for the next two decades. St. Jude's, as well as, MDT and BSX, big pharm, other health-care suppliers are the right businesses at the right time. They have to be really badly managed to screw this up.

Recs

1
Member Avatar lionel319 (86.58) Submitted: 3/17/2010 11:24:35 PM : Outperform Start Price: $36.36 STJ Score: -7.30

http://caps.fool.com/Blogs/ViewPost.aspx?bpid=350402&t=01001644285823293180

Recs

0
Member Avatar iddqkfyou (< 20) Submitted: 2/15/2010 5:51:05 AM : Outperform Start Price: $34.99 STJ Score: -6.49

Growing revenue and profit, and an insider made a large purchase recently.

Recs

0
Member Avatar TheBigLab (56.87) Submitted: 7/22/2009 10:15:36 PM : Outperform Start Price: $33.93 STJ Score: -27.49

More people will get medical help

Recs

0
Member Avatar buzzstocks (< 20) Submitted: 4/17/2009 5:33:42 PM : Outperform Start Price: $33.30 STJ Score: -50.19

Life-saving devices that target heart disease. Higher than expected Q3 sales, and well insulated from macro turmoil.

Recs

0
Member Avatar iskabible (38.54) Submitted: 2/11/2009 6:20:08 PM : Outperform Start Price: $34.24 STJ Score: -66.82

Mad Money

Results 1 - 20 of 60 : 1 2 3 Next »

Featured Broker Partners


Advertisement